Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors
Reuters
Tue, 09/2/14 - 10:05 am
Tags:
AstraZeneca
,
M&A
,
Pfizer
,
Pharma CEOs
,
Pascal Soriot
Astra heart pill safe to use in ambulance but no extra benefit
Yahoo/Reuters
Mon, 09/1/14 - 09:40 am
Tags:
AstraZeneca
,
heart attack
,
Brilinta
Investors Bet AstraZeneca Megamerger Could Live Again
Bloomberg
Fri, 08/29/14 - 03:04 pm
Tags:
M&A
,
AstraZeneca
,
Pfizer
Is Pfizer now eyeing up Actavis three months after failed AZ bid?
In-Pharma Technologist
Fri, 08/29/14 - 08:12 am
Tags:
M&A
,
Actavis
,
Pfizer
,
AstraZeneca
AstraZeneca buoyed by Pfizer takeover talks, colorectal cancer study for MEDI-4736
First Word Pharma
Fri, 08/29/14 - 08:07 am
Tags:
colon cancer
,
AstraZeneca
,
Pfizer
,
M&A
,
MEDI-4736
AstraZeneca Pops on Possibility of Another Pfizer Bid
WSJ Online
Thu, 08/28/14 - 07:18 pm
Tags:
Pfizer
,
AstraZeneca
,
M&A
Does Pfizer still need AstraZeneca's vaccines business?
Fierce Vaccines
Thu, 08/28/14 - 11:08 am
Tags:
Pfizer
,
M&A
,
vaccines
,
AstraZeneca
,
Prevnar 13
Big Pharma, Big Biotech prepare for showdown in next-gen psoriasis market
Fierce Pharma Marketing
Wed, 08/27/14 - 10:22 am
Tags:
Embrel
,
Amgen
,
Pfizer
,
Eli Lilly
,
Novartis
,
Celgene
,
psoriasis
,
AstraZeneca
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Tags:
Keryx
,
Orexigen
,
AstraZeneca
,
Nektar
,
Salix
,
Alimera
,
Amarin
,
Merck
,
EXACT Sciences
,
NPS Pharmaceuticals
Pfizer/AstraZeneca: Ready for round 2?
CNBC
Tue, 08/26/14 - 08:24 am
Tags:
M&A
,
Pfizer
,
AstraZeneca
The 4 Companies Teaming Up For A New Tool To Fight Cancer
Yahoo/Benzinga
Mon, 08/25/14 - 10:17 pm
Tags:
cancer
,
JNJ
,
Illumina
,
AstraZeneca
,
Sanofi
,
MiSeqDx
,
DNA sequencing
AstraZeneca Updates on PLATO Study Investigation on Brilinta
Yahoo/Zacks
Sat, 08/23/14 - 09:39 am
Tags:
AstraZeneca
,
Brilinta
Pfizer back for AstraZeneca? Year-end move seen most likely
Yahoo/Reuters
Thu, 08/21/14 - 10:42 am
Tags:
Pfizer
,
M&A
,
AstraZeneca
Pfizer looks at possible Actavis bid whilst weighing next steps over AstraZeneca: report
First Word Pharma
Thu, 08/21/14 - 10:02 am
Tags:
Pfizer
,
Actavis
,
AstraZeneca
,
M&A
Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology
Yahoo
Thu, 08/21/14 - 08:10 am
Tags:
Illumina
,
AstraZeneca
,
Janssen
,
Sanofi
,
diagnostics
,
cancer
AstraZeneca Is Tougher Target for Possible New Pfizer Bid
Bloomberg
Thu, 08/21/14 - 07:48 am
Tags:
Pfizer
,
AstraZeneca
,
M&A
AstraZeneca reports positive Phase III data for experimental antibiotic ceftazidime-avibactam
First Word Pharma
Tue, 08/19/14 - 09:50 am
Tags:
AstraZeneca
,
antibiotics
,
CAZ-AVI
The Negative Impact Of Pfizer's Mergers And Budget Cuts On Cancer R&D
Forbes
Tue, 08/19/14 - 08:41 am
Tags:
Pfizer
,
M&A
,
R&D
,
AstraZeneca
U.S. clears AstraZeneca over heart drug trial
Yahoo/Reuters
Tue, 08/19/14 - 08:05 am
Tags:
AstraZeneca
,
Brilinta
,
DOJ
Most Popular News Headlines For Thursday, August 14 2014
CP Wire
Fri, 08/15/14 - 06:19 am
Tags:
FDA
,
Kyprolis
,
Amgen
,
asthma
,
AstraZeneca
,
AbbVie
,
orphan drugs
,
ABT-414
,
female se
Pages
« first
‹ previous
…
92
93
94
95
96
97
98
99
100
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.